5-year Recurrence-Free Survival Estimates Training Set Median follow-up 42.23 months (1.45-246.40 months) | |||||
---|---|---|---|---|---|
 | No. at Risk | No. of Events | 5-Year Estimate | 95% Confidence Interval | P-Value |
All | 446 | 106 | 0.699 | (0.65, 0.751) | Â |
Prognostic Group 1 | 108 | 17 | 0.809 | (0.730, 0.896) | Â |
Prognostic Group 2 | 84 | 7 | 0.876 | (0.793, 0.968) | Â |
Prognostic Group 3 | 44 | 8 | 0.758 | (0.620, 0.926) | Â |
Prognostic Group 4 | 73 | 22 | 0.595 | (0.464, 0.763) | Â |
Prognostic Group 5 | 109 | 36 | 0.576 | (0.472, 0.703) | Â |
Prognostic Group 6 | 28 | 16 | 0.299 | (0.152, 0.589) | 8.88E-10 |
5-year Recurrence-Free Survival Estimates Test Set Median follow-up 217 months (180-259 months) | |||||
 | No. at Risk | No. of Events | 5-Year Estimate | 95% Confidence Interval | P-Value |
All | 166 | 92 | 0.446 | (0.376, 0.528) | Â |
Prognostic Group 1 | 33 | 18 | 0.455 | (0.313, 0.661) | Â |
Prognostic Group 2 | 45 | 17 | 0.622 | (0.496, 0.781) | Â |
Prognostic Group 3 | 15 | 5 | 0.667 | (0.466, 0.953) | Â |
Prognostic Group 4 | 22 | 16 | 0.273 | (0.138, 0.540) | Â |
Prognostic Group 5 | 20 | 14 | 0.300 | (0.154, 0.586) | Â |
Prognostic Group 6 | 31 | 22 | 0.290 | (0.167, 0.503) | 0.0013 |